COVID-19 resources for managing endocrine conditions
We are collating resources relating to COVID-19 and endocrine practice for your information and to share with your colleagues.
This resource has been created to address uncertainty and provide guidance and support to colleagues at this challenging time (this advice is NOT intended for patient use).
If you have documents to share, please send them to clinical@endocrinology.org
Our Clinical Committee will review them and they will be uploaded to this page as quickly as possible. This page will be updated regularly.
General
- Q&A on the impact of COVID-19 on research funded or supported by NIHR
- Identifying and helping to protect patients most at risk from COVID-19 (RCP)
- Specialty-specific guidance on aspects of clinical care and treatment for COVID-19 from the RCP
- Medical research charities and COVID-19: AMRC’s response and key guidance
- RGCP primary care resource hub to support GPs
- Specialist Pharmacy Service COVID-19 Work Programme
- Specialist Pharmacy Service COVID-19 SPS advice, news and updates
- EJE Collection: Endocrinology in the time of COVID
Androgen replacement
Cushing's Syndrome
Diabetes Inspidus
- EJE Collection COVID-19 series: Management of Hyponatraemia and Diabetes Insipidus in the time of COVID-19
- Guidance for patients with diabetes insipidus in the era of COVID-19
Diabetes Mellitus
- Association of British Clinical Diabetologists (ABCD) COVID-19 resource page
- EJE Collection COVID-19 series: Diagnosis and Management of Gestational Diabetes Mellitus
- EJE Collection COVID-19 series: Remodelling Diabetes Services and Promoting Innovation
Endocrine Surgery
- BAETS statement on COVID-19 and parathyroid disease
- BAETS statement on COVID-19 and benign thyroid disease
- BAETS prioritisation advice for paediatric endocrine surgery during COVID-19 crisis
- BAETS Prioritisation advice for adult endocrine surgery during COVID-19 crisis
Fertility treatment
Genetic haemochromatosis
Growth hormone
Neuroendocrine tumours
- Management of patients with neuroendocrine tumours/neuroendocrine cancer
- EJE Collection COVID-19 series: Management of neuroendocrine neoplasms (NENs)
Osteoporosis & calcium metabolic disorders
- LETTER TEMPLATE- Denosumab Injection During COVID-19 (Hospital Administration)
- LETTER TEMPLATE- Denosumab Injection During COVID-19 (Self-Administration)
- Prolia patient information leaflet 2020
- Postponement of zoledronic acid Infusions - letter template
- Royal Osteoporosis Society advice and information page for osteoporosis
- Protocol for Prolia
- EJE Collection COVID-19 series: Management of calcium metabolic disorders and osteoporosis
Parathyroid
- Coronavirus (COVID-19) and parathyroid conditions FAQs
- Template letter COVID-19 and hypoparathyroidism
Pituitary/adrenal insufficiency
- EJE Collection COVID-19 series: Management of adrenal insufficiency
- Adrenal Crisis Information page
- NHS Emergency Steroid Card (download)
- LETTER TEMPLATE updated advice for AI patients
- Advice for patients who take replacement steroids (hydrocortisone, prednisolone, dexamethasone or plenadren) for pituitary/adrenal insufficiency.
Pituitary tumours
Thyroid dysfunction
- Management of thyroid dysfunction during the COVID -19
- Management of thyrotoxicosis during COVID-19
- Letter Template - Radioactive iodine treatment -COVID-19
- EJE Collection COVID-19 series: Management of hyper- and hypo- thyroidism
Thyroid cancer
- Management of thyroid cancer during COVID-19
- Radioactive Iodine Treatment during COVID-19 pandemic
- EJE Collection COVID-19 series: Management of thyroid nodules and cancer
Thyroid eye disease
Turner Syndrome
Vitamin D
- RCP, British Dietetic Association and Society for Endocrinology joint statement on COVID-19 and vitamin D (general population)
- Society for Endocrinology advice for vitamin D deficient patients in the times of COVID-19
Please note that these resources are not Society endorsed but have been supplied by members in response to clinical practice management during the COVID-19 crisis.